TY - JOUR
T1 - Treatment of lentigo maligna with tazarotene 0.1% gel
AU - Chimenti, Sergio
AU - Carrozzo, Anna Maria
AU - Citarella, Luigi
AU - De Felice, Catia
AU - Peris, Ketty
PY - 2004/1
Y1 - 2004/1
N2 - We report 2 elderly patients with facial lentigo maligna who experienced complete regression, both clinically and histopathologically, after once-daily topical treatment with tazarotene 0.1% gel for 6 to 8 months. After a follow-up period of 18 and 30 months, no recurrence was observed. We believe that tazarotene might be considered as an alternative medical approach in selected patients with lentigo maligna.
AB - We report 2 elderly patients with facial lentigo maligna who experienced complete regression, both clinically and histopathologically, after once-daily topical treatment with tazarotene 0.1% gel for 6 to 8 months. After a follow-up period of 18 and 30 months, no recurrence was observed. We believe that tazarotene might be considered as an alternative medical approach in selected patients with lentigo maligna.
UR - http://www.scopus.com/inward/record.url?scp=0346373728&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0346373728&partnerID=8YFLogxK
U2 - 10.1016/j.jaad.2003.07.005
DO - 10.1016/j.jaad.2003.07.005
M3 - Article
C2 - 14699375
AN - SCOPUS:0346373728
SN - 0190-9622
VL - 50
SP - 101
EP - 103
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 1
ER -